Roth Capital Partners is acting as manager.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TENX:
- Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board
- Tenax Therapeutics appoints Butler to PH-HFpEF SAB
- Biotech Alert: Searches spiking for these stocks today
- Tenax Therapeutics cleared for TNX-103 Phase 3 trials, says Roth MKM
- Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023